02487.HK
Cutia Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 1.20
−11.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 6.52x
- P/E 2028E
- 2.58x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.53x
- Price / sales
- 1.13x
- Price / cash flow
- -3.13x
Enterprise value
- Enterprise value
- HKD 25.8M
- EV / sales
- 0.07x
- EV / EBITDA
- -0.10x
- EV / EBIT
- -0.09x
- Market cap
- HKD 437.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026